Evidence map›Paper›PMID 33087250›Full record

Trial reportClinical nutrition (Edinburgh, Scotland)2021

Metabolomic basis for response to high dose vitamin D in critical illness.

Karin Amrein, Jessica A Lasky-Su, Harald Dobnig, Kenneth B Christopher

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical nutrition (Edinburgh, Scotland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. High-resolution plasma metabolomics and thiamine status in critically Ill adult patients.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  11. Article
  12. Maternal vitamin D-related metabolome and offspring risk of asthma outcomes.The Journal of allergy and clinical immunology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Does Vitamin D Improve All-cause Mortality in Critically Ill Adults? An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Karin AmreinDivision of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
Jessica A Lasky-SuChanning Division of Network Medicine, Brigham and Women's Hospital, USA.
Harald DobnigThyroid Endocrinology Osteoporosis Institute Dobnig, Graz, Austria.
Kenneth B ChristopherDivision of Renal Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, USA. Electronic address: kbchristopher@bwh.harvard.edu.
Brigham and Women's Hospital · USMedical University of Graz · AT

Funding

Pharmacokinetics and metabolomics of vitamin D supplementation in critical illnessR01GM115774 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CHRISTOPHER, KENNETH BRUCE · 2016 to 2018
$940k
NIGMS NIH HHS R01 GM115774
6 · The paper itself

Abstract

BACKGROUND &

aimsIt is unclear if intervention can mitigate the dramatic alterations of metabolic homeostasis present in critical illness. Our objective was to determine the associations between increased 25-hydroxyvitamin D levels following high dose vitamin D

methodsWe performed a post-hoc metabolomics study of the VITdAL-ICU randomized double-blind, placebo-controlled trial. Trial patients from Medical and Surgical Intensive Care Units at a tertiary university hospital with 25-hydroxyvitamin D level ≤20 ng/mL received either high dose oral vitamin D

results55.2% of subjects randomized to high dose vitamin D

conclusionsIncreases in 25-hydroxyvitamin D following vitamin D

Indexed as

MetabolomicsAgedAged, 80 and overCholecalciferolCritical IllnessDouble-Blind MethodFemaleHumansIntensive Care UnitsLysophospholipidsMaleMiddle AgedPlacebosPlasmalogensSphingomyelinsTreatment Outcome25-hydroxyvitamin DCholecalciferolLysophospholipidsPlacebosPlasmalogensSphingomyelinsVitamin DAcylcarnitineCritical illnessMetabolomicsPhosphatidylethanolaminePlasmalogenVitamin D

Identifiers

PMID33087250
PMCPMC8826589
OpenAlexW3089181182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.